Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-23 4:11 pm Sale | 2022-08-16 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,579,285 72.100% | -29,339 (-1.82%) | Filing History |
| 2022-06-24 4:17 pm Purchase | 2022-06-06 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,608,624 72.500% | 304,289 (+23.33%) | Filing History |
| 2022-04-11 4:16 pm Sale | 2022-04-04 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,304,335 68.100% | -85,253 (-6.14%) | Filing History |
| 2022-02-22 4:16 pm Purchase | 2022-02-14 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,389,588 69.500% | 266,712 (+23.75%) | Filing History |
| 2022-02-14 4:40 pm Sale | 2022-02-03 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,122,876 64.800% | -135,234 (-10.75%) | Filing History |
| 2021-12-13 4:16 pm Purchase | 2021-12-06 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,258,109 67.300% | 216,703 (+20.81%) | Filing History |
| 2021-11-18 4:15 pm Unchanged | 2021-11-08 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,041,406 63.000% | 0 (Unchanged) | Filing History |
| 2021-11-02 4:15 pm Purchase | 2021-10-25 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 1,041,406 63.000% | 107,915 (+11.56%) | Filing History |
| 2021-09-14 4:17 pm Purchase | 2021-07-13 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 933,491 60.400% | 115,760 (+14.16%) | Filing History |
| 2021-05-26 4:15 pm Purchase | 2021-05-24 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 817,731 57.200% | 36,429 (+4.66%) | Filing History |
| 2021-05-11 4:17 pm Purchase | 2021-04-26 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 781,302 56.100% | 107,439 (+15.94%) | Filing History |
| 2021-02-17 4:40 pm Purchase | 2021-02-10 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 673,863 52.700% | 4,797 (+0.72%) | Filing History |
| 2021-02-09 4:15 pm Sale | 2021-02-05 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 669,065 52.600% | -3,643 (-0.54%) | Filing History |
| 2021-01-12 4:18 pm Purchase | 2021-01-08 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 672,709 52.700% | 68,800 (+11.39%) | Filing History |
| 2020-11-19 5:24 pm Unchanged | 2020-11-11 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 603,908 50.000% | 0 (Unchanged) | Filing History |
| 2020-10-16 4:35 pm Sale | 2020-10-08 | 13G | AgeX Therapeutics, Inc. AGE | IBS CAPITAL LLC | 53,561 4.998% | -23,543 (-30.53%) | Filing History |
| 2020-10-07 4:16 pm Purchase | 2020-10-02 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 603,908 50.000% | 868 (+0.14%) | Filing History |
| 2020-07-31 4:02 pm Purchase | 2020-07-21 | 13D | AgeX Therapeutics, Inc. AGE | Juvenescence Ltd | 603,040 50.000% | 124,285 (+25.96%) | Filing History |